Compare ALRS & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALRS | IRWD |
|---|---|---|
| Founded | 1879 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 631.1M | 741.8M |
| IPO Year | 2019 | 2009 |
| Metric | ALRS | IRWD |
|---|---|---|
| Price | $23.57 | $3.07 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $25.40 | $4.94 |
| AVG Volume (30 Days) | 106.1K | ★ 2.5M |
| Earning Date | 04-27-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | N/A | ★ 1400.00 |
| EPS | ★ 0.68 | 0.15 |
| Revenue | N/A | ★ $298,276,000.00 |
| Revenue This Year | $38.81 | $57.95 |
| Revenue Next Year | $4.72 | $4.39 |
| P/E Ratio | $35.53 | ★ $21.00 |
| Revenue Growth | N/A | ★ 8.88 |
| 52 Week Low | $15.82 | $0.55 |
| 52 Week High | $26.32 | $5.78 |
| Indicator | ALRS | IRWD |
|---|---|---|
| Relative Strength Index (RSI) | 44.29 | 37.44 |
| Support Level | $23.09 | $1.38 |
| Resistance Level | $23.99 | $3.92 |
| Average True Range (ATR) | 0.54 | 0.22 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 40.61 | 2.81 |
Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.